Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

USGI Medical Tissue Anchors Show Durability Beyond One Year, Enabling Numerous Incisionless Gastrointestinal Procedures

September 14, 2010 11:07 am | News | Comments

SAN CLEMENTE, Calif. (September 13, 2010) – USGI Medical, Inc., the Incisionless Surgery company, today announced that updated multi-center results confirm durability of the company’s Expandable Tissue Anchors™

TOPICS:

IntriMed Technologies Launched to Address Challenges Faced by Medical Device Manufacturers

September 14, 2010 10:58 am | News | Comments

Oxnard, Calif. – Sept. 14, 2010 – The launch of IntriMed Technologies and the opening of IntriMed’s first state-of-the-industry Innovation Center in Oxnard, Calif. were announced today by IntriPlex Technologies, a global leader in the design and manufacture of ultra-precise components for the data storage and healthcare industries.

DSM Biomedical Announces Continued Partnership with Spinelab

September 14, 2010 9:50 am | News | Comments

Berkeley, CA – September 14, 2010 – DSM Biomedical, a global leader in biomedical materials science, and its Berkeley based operation, DSM PTG, today announced the company has extended its partnership with Spinelab Ltd., a privately held company specialized in developing a dynamic stabilization system for the spine.

TOPICS:
Advertisement

Connecticut Spring & Stamping Announces Medical Capabilities

September 14, 2010 9:43 am | News | Comments

Connecticut Spring & Stamping (CSS), a manufacturer of precision parts for the medical, aerospace, firearms and defense industries worldwide, announces its broad technical expertise in developing and manufacturing precision medical product components, including springs and progressive stampings.

TOPICS:

Humana hiring 270 workers for Humana Cares unit

September 14, 2010 8:45 am | by The Associated Press | News | Comments

Health insurer Humana Inc. said Tuesday it is adding 270 new positions to its Humana Cares unit.Humana Cares, based in St. Petersburg, Fla., is the company's complex care management division. It focuses on patients with chronic disease, including heart and lung conditions.The hiring comes ahead...

Humidifiers Just Got More Fun for Kids - Vicks Launches Starry Night Cool Moisture Humidifier

September 14, 2010 7:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 14 /- Getting kids excited about humidifiers is tough to say the least, particularly when they're dragged out of the closet only when little ones are sick.  The American Academy of Pediatrics, however, recommends using a cool mist humidifier throughout the winter...

TOPICS:

Palmetto Health Richland Hospital Becomes First in South Carolina to Noninvasively, Wirelessly Monitor Patients Using State-of-the-Art Masimo Patient SafetyNet™ System

September 14, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Sept. 14 /- Palmetto Health Richland in Columbia—South Carolina's largest and most comprehensive healthcare resource, and Masimo (Nasdaq: MASI ) today jointly announced South Carolina's first installation of Masimo Patient SafetyNet, an advanced remote monitoring and...

TOPICS:

Clinical Experts Detail How They Use Varian's TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments

September 14, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

BARCELONA, Spain, Sept. 14 /- Cancer treatment experts today reported their experiences with early treatments using the new TrueBeam system from Varian Medical Systems (NYSE: VAR ), aimed at increasing the speed and precision of radiotherapy and radiosurgery treatments. Clinicians from...

TOPICS:
Advertisement

ASU receives 2-year, $5.3 million DARPA award to safeguard soldiers from infectious diseases

September 14, 2010 7:35 am | by EurekAlert | News | Comments

(Arizona State University) Scientists at the Biodesign Institute at Arizona State University have received a 2-year, $5.3 million grant from the Defense Advanced Research Projects Agency to protect warfighters in the event of exposure to infectious diseases during deployment. Dr. Stephen...

TOPICS:

Corgenix to Host Conference Call to Discuss Fiscal 2010 Results

September 14, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

DENVER, Sept. 14 /- Corgenix Medical Corporation (OTC Bulletin Board: CONX ), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Thursday, September 23, 2010, at 4:00 PM EDT to discuss the Company's financial and operating performance for its fiscal...

TOPICS:

Federal Register: Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting

September 14, 2010 7:31 am | by U.S. Food & Drug Administration | News | Comments

On October 8, 2010, the committee will discuss and make recommendations regarding clinical trial design issues for devices indicated for the treatment of depression.

TOPICS:

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

September 14, 2010 5:32 am | by Boston Scientific | News | Comments

Company to present clinical data on its platinum chromium PROMUS® Element™ and TAXUS® Element™ Coronary Stent Systems

TOPICS:

Alere looking for $350M from notes placement

September 14, 2010 4:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Alere Inc., the Waltham life sciences firm formerly known as Inverness Medical Innovations Inc., plans to raise $350 million through a private placement of senior subordinated notes, with proceeds being used for working capital and general purposes.

Isis Pharmaceuticals to Present at the UBS Global Life Sciences Conference

September 14, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Sept. 14 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at UBS' Global Life Sciences Conference on Tuesday, September 21, 2010 at 4:00 p.m. ET at the Grand Hyatt New...

TOPICS:

Quinton Oswald Named Chief Executive Officer of SARcode Corporation

September 14, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

BRISBANE, Calif., Sept. 14 /- SARcode Corporation, a privately-held biotechnology company focused on developing a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists, today announced that Quinton Oswald has joined the company as Chief Executive Officer. Mr. Oswald...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading